Yungjin Pharmaceutical Company Limited (003520) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Yungjin Pharmaceutical Company Limited Company Snapshot

Business Description:

Yungjin Pharmaceutical Company Limited operates in the Medicinals and botanicals sector. Yungjin Pharm. Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company's products include antibiotics, respiratory drugs, infections, antipyretics, analgesics, central nervous system (CNS) drugs, gastrointestinal (GI) drugs, cardiovascular (CV) drugs, antihistamines, antifungals, antidiabetics, healthcare drugs, tonic drinks and others under the brand names SAGACIN, COLMIN A, DENOGAN, LODOPINE, APLACE, YoungJin Glucosamin-S, Rosuvastatin, BORAZOL, PLAKON, GLITZONE and COOL SHOT. The Company operates its business within domestic market and in overseas markets, including Japan and China, Argentina, Italy, France, Germany, Israel. In our complete report available for purchase the company is compared to: Samil Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industrial Company Limited and CKD Bio Corp.

Yungjin Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 1,940.00
(Figures in Korean Won)

1 Week	0.5%	13 Weeks	-18.5%

4 Weeks	121.0%	52 Weeks	127.7%

Yungjin Pharmaceutical Company Limited Key Data:

Ticker:	003520	Country:	KOREA (SOUTH)

Exchanges:	SEO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Diversified Drugs, Cosmetics, & Health Care

2010 Sales	116,317,390,000 (Year Ending Jan 2011).	Employees:	534

Currency:	Korean Won	Market Cap:	344,582,295,600

Fiscal Yr Ends:	December	Shares Outstanding:	177,619,740

Share Type:	Common	Closely Held Shares:	106,920,415

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.